Vassilios Lougaris

ORCID: 0000-0003-2303-9533
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Immunodeficiency and Autoimmune Disorders
  • T-cell and B-cell Immunology
  • Immune Cell Function and Interaction
  • Chronic Lymphocytic Leukemia Research
  • Blood disorders and treatments
  • Platelet Disorders and Treatments
  • Cystic Fibrosis Research Advances
  • Diabetes and associated disorders
  • NF-κB Signaling Pathways
  • Blood groups and transfusion
  • Immune Response and Inflammation
  • PI3K/AKT/mTOR signaling in cancer
  • Cytomegalovirus and herpesvirus research
  • Congenital Ear and Nasal Anomalies
  • Gastrointestinal disorders and treatments
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Chemokine receptors and signaling
  • Parvovirus B19 Infection Studies
  • Pediatric health and respiratory diseases
  • Neonatal Respiratory Health Research
  • Celiac Disease Research and Management
  • Lymphoma Diagnosis and Treatment
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Asthma and respiratory diseases

Brescia University
2002-2024

University of Brescia
2015-2024

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
2015-2024

Federico II University Hospital
2024

Weatherford College
2022

Institute for Molecular Medicine
2022

University of South Florida
2022

Flinders Medical Centre
2022

Flinders University
2022

Hospital Sant Joan de Déu Barcelona
2021

10.1016/j.jaci.2018.02.055 article EN publisher-specific-oa Journal of Allergy and Clinical Immunology 2018-05-04

There is uncertainty about the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in individuals with rare inborn errors immunity (IEI), a population at risk developing disease 2019. This relevant not only for these patients but also general population, because studies IEIs can unveil key requirements host defense.

10.1016/j.jaci.2020.09.010 article EN cc-by-nc-nd Journal of Allergy and Clinical Immunology 2020-09-24

Activated phosphoinositide 3-kinase δ syndrome (APDS) 2 (p110δ-activating mutations causing senescent T cells, lymphadenopathy, and immunodeficiency [PASLI]-R1), a recently described primary immunodeficiency, results from autosomal dominant in PIK3R1, the gene encoding regulatory subunit (p85α, p55α, p50α) of class IA 3-kinases.We sought to review clinical, immunologic, histopathologic phenotypes APDS2 genetically defined international patient cohort.The medical biological records 36...

10.1016/j.jaci.2016.03.022 article EN cc-by-nc-nd Journal of Allergy and Clinical Immunology 2016-04-30

Abstract Activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) is an inborn error of immunity with clinical manifestations including infections, lymphoproliferation, autoimmunity, enteropathy, bronchiectasis, increased risk lymphoma, and early mortality. Hyperactive PI3Kδ signaling causes APDS selectively targeted leniolisib, oral, small molecule inhibitor PI3Kδ. Here, 31 patients aged ≥12 years were enrolled in a global, phase 3, triple-blinded trial randomized 2:1 to receive 70...

10.1182/blood.2022018546 article EN cc-by-nc-nd Blood 2022-11-18

Interferon (IFN) consensus sequence-binding protein/IFN regulatory factor 8 (IRF8) is a transcription that regulates the differentiation and function of macrophages, granulocytes, dendritic cells through activation or repression target genes. Although IRF8 also expressed in lymphocytes, its roles B cell T maturation are ill defined, few transcriptional targets known. Gene expression profiling human tonsillar mouse lymphomas showed transcripts were at highest levels centroblasts, either from...

10.1084/jem.20051450 article EN The Journal of Experimental Medicine 2005-12-27

The TNF family member protein BAFF/BLyS is essential for B cell survival and plays an important role in regulating class switch recombination as well the selection of autoreactive cells. In humans, increased concentrations soluble BAFF are found different pathological conditions, which may be diverse autoimmune diseases, malignancies, primary Ab deficiencies (PAD). Because mechanisms that regulate levels not understood, we newly developed a set mAbs against human to study parameters...

10.4049/jimmunol.1102321 article EN The Journal of Immunology 2011-11-30

We aimed to test the relevance of deficiency adenosine deaminase 2 (DADA2) in patients with antibody and describe clinical picture disease adulthood.We screened for DADA2 a cohort 181 or without vascular lesions using next-generation sequencing targeted Sanger sequencing. All mutations were confirmed by determining ADA2 enzymatic activity levels dried plasma spots. Clinical data laboratory values collected standardized format.Following diagnosis siblings index family, we identified 9...

10.1002/art.40147 article EN Arthritis & Rheumatology 2017-05-10
Tiziana Lorenzini Manfred Fliegauf Nils Klammer Natalie Frede Michele Proietti and 95 more Alla Bulashevska Nadezhda Camacho-Ordóñez Markku Varjosalo Matias Kinnunen Esther de Vries J.W.M. van der Meer Rohan Ameratunga Chaim M. Roifman Yael Dinur Schejter Robin Kobbe Timo Hautala Faranaz Atschekzei Reinhold E. Schmidt Claudia Schröder Polina Stepensky Bella Shadur Luis Alberto Pedroza Michiel van der Flier Mónica Martínez‐Gallo Luis Ignacio González‐Granado Luís M. Allende Anna Shcherbina N. B. Kuzmenko V.P. Zakharova João Farela Neves Peter Švec Ute Fischer Winnie Ip Oliver Bartsch Safa Barış Christoph Klein Raif S. Geha Janet Chou Mohammed F. Alosaimi Lauren Weintraub Kaan Boztuğ Tatjana Hirschmugl Maria Marluce dos Santos Vilela Dirk Holzinger Maximilian Seidl Vassilios Lougaris Alessandro Plebani Laia Alsina M. Piquer‐Gibert Àngela Deyà‐Martínez C Slade Asghar Aghamohammadi Hassan Abolhassani Lennart Hammarström Outi Kuismin Merja Helminen Hana Lango Allen James E. Thaventhiran Alexandra F. Freeman Matthew Cook Shahrzad Bakhtiar Mette Christiansen Charlotte Cunningham‐Rundles Niraj Patel William Rae Tim Niehues Nina Brauer Jaana Syrjänen Mikko Seppänen Siobhan O. Burns Paul Tuijnenburg Taco W. Kuijpers Klaus Warnatz Bodo Grimbacher Zoe Adhya Hana Alachkar Ariharan Anantharachagan Richard Antrobus Gururaj Arumugakani Sofie Ashford William J. Astle Anthony Attwood Chiara Bacchelli Joana Batista Helen Baxendale Claire Bethune Shahnaz Bibi Marta Bleda Barbara Boardman Claire Booth John R. Bradley Gerome Breen Matthew A. Brown Michael J. Browning Mary Brownlie Matthew Buckland Siobhan O. Burns Oliver S. Burren Keren Carss John C. Chambers

10.1016/j.jaci.2019.11.051 article EN Journal of Allergy and Clinical Immunology 2020-04-09

Memory B cells (MBCs) epitomize the adaptation of immune system to environment. We identify two MBC subsets in peripheral blood, CD27dull and CD27bright MBCs, whose frequency changes with age. Heavy chain variable region (VH) usage, somatic mutation replacement-to-silent ratio, CDR3 property changes, reflecting consecutive selection highly antigen-specific, low cross-reactive antibody variants, all demonstrate that MBCs represent sequential developmental stages, stringent antigen-driven...

10.1016/j.celrep.2020.02.022 article EN cc-by-nc-nd Cell Reports 2020-03-01

Clinical Implications•Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive patients with inborn errors of immunity (IEI) showed a similar infection-fatality rate, lower incidence in pediatric age, and younger age at death than the SARS-CoV-2–positive Italian population. The fatality rate was previously reported from other IEI cohorts. Antibody deficiencies long-lasting SARS-CoV-2 positivity. •Severe Early reports described an unexpected low number affected by severe...

10.1016/j.jaip.2021.04.017 article EN cc-by-nc-nd The Journal of Allergy and Clinical Immunology In Practice 2021-04-01
Maria Elena Maccari Martin Wolkewitz Charlotte Schwab Tiziana Lorenzini Jennifer W. Leiding and 95 more Nathalie Aladjdi Hassan Abolhassani Wadih Abou‐Chahla Alessandro Aiuti Saba Azarnoush Safa Barış Vincent Barlogis Federica Barzaghi Ulrich Baumann Markéta Bloomfield Nadezda Bohynikova Damien Bodet David Boutboul Giorgia Bucciol Matthew Buckland Siobhan O. Burns Caterina Cancrini P. Cathébras Marina Cavazzana Morgane Cheminant Matteo Chinello Peter Čižnár Tanya Coulter Maud D’Aveni Olov Ekwall Želimir Erić Efrem Eren Anders Fasth Pierre Frange Benjamin Fournier Marina García-Prat Martine Gardembas Christoph B. Geier Sujal Ghosh Vera Goda Lennart Hammarström Fabian Hauck Maximilian Heeg Edyta Heropolitańska–Pliszka Anna Hilfanova Stephen Jolles Elif Karakoç-Aydıner Gerhard Kindle Ayça Kıykım Christian Klemann Patra Koletsi Sylwia Kołtan Irina Kondratenko Julia Körholz Renate Krüger Éric Jeziorski Romain Lévy G. Le Guenno Guillaume Lefèvre Vassilios Lougaris Antonio Marzollo Nizar Mahlaoui Marion Malphettes Andrea Meinhardt Étienne Merlin Isabelle Meyts Tomáš Milota Fernando Moreira Despina Moshous Anna Mukhinа Olaf Neth Jennifer Neubert Bénédicte Neven Alexandra Nieters R. Nové-Josserand Éric Oksenhendler Ahmet Özen Peter Olbrich Antoinette Perlat Małgorzata Pac Jana Pachlopnik Schmid Lucia Pacillo Alba Parra-Martínez Olga Paschenko Isabelle Pellier Asena Pınar Sefer Alessandro Plebani Dominique Plantaz Seraina Prader L. Raffray Henrike Ritterbusch Jacques G. Rivière Beatrice Rivalta Stephan Rusch Inga Sakovich Sinisa Savic Raphael Scheible N. Schleinitz Catharina Schuetz Ansgar Schulz

10.1016/j.jaci.2023.06.015 article EN Journal of Allergy and Clinical Immunology 2023-06-28

Gastrointestinal manifestations and villous atrophy can be seen in patients with common variable immunodeficiency (CVID). In some patients, infectious agents may responsible, whereas others, celiac disease (CD) the cause. this study, we investigate causes histopathologic features CVID. Eleven CVID underwent duodenal biopsies, human leukocyte antigen (HLA) typing, testing for all antibodies. Fifteen normal villi 6 CD but without served as controls. Histologic response to a gluten-free diet...

10.1309/ajcpeiilh2c0wfye article EN American Journal of Clinical Pathology 2012-08-01

BackgroundLacking protective antibodies, patients with primary antibody deficiencies (PADs) experience frequent respiratory tract infections, leading to chronic pulmonary damage. Macrolide prophylaxis has proved effective in diseases.ObjectiveWe aimed test the efficacy and safety of orally administered low-dose azithromycin PADs.MethodsWe designed a 3-year, double-blind, placebo-controlled, randomized clinical trial whether oral (250 mg once daily 3 times week for 2 years) would reduce...

10.1016/j.jaci.2019.01.051 article EN cc-by-nc-nd Journal of Allergy and Clinical Immunology 2019-03-22

Background: Recently, a growing number of novel genetic defects underlying primary immunodeficiencies (PID) have been identified, increasing the PID up to more than 250 well-defined forms. Next-generation sequencing (NGS) technologies and proper filtering strategies greatly contributed this rapid evolution, providing possibility rapidly simultaneously analyze large numbers genes or whole exome. Objective: To evaluate role targeted next-generation exome in diagnosis case series, characterized...

10.3389/fimmu.2016.00466 article EN cc-by Frontiers in Immunology 2016-11-07

Article21 January 2021Open Access Source DataTransparent process Modeling, optimization, and comparable efficacy of T cell hematopoietic stem gene editing for treating hyper-IgM syndrome Valentina Vavassori San Raffaele Telethon Institute Gene Therapy, IRCCS Scientific Institute, Milan, Italy Vita-Salute University, ItalyThese authors contributed equally to this work Search more papers by author Elisabetta Mercuri Milano-Bicocca Monza, Genni E Marcovecchio Maria C Castiello Genetic...

10.15252/emmm.202013545 article EN cc-by EMBO Molecular Medicine 2021-01-21
Coming Soon ...